Dr. Candace M. Thrash, MD

Dr. Thrash practices at Sanova Dermatology in Pflugerville, Texas.

Dr. Thrash's NPI, 1093764664, was assigned on May 9, 2006. Dr. Thrash graduated from Joe R. & Teresa Lozano Long School of Medicine in 1999. Dr. Thrash holds Texas license L8216.

Dr. Thrash's primary practice is Sanova Dermatology, at 1601 E Pflugerville Pkwy, Pflugerville, TX 78660 in Travis County. The practice phone is (512) 837-3376.

Dr. Thrash's primary practice is Sanova Dermatology in Pflugerville, Texas. The medical group on file is Sanova Dermatology. Dmand AI also links Dr. Thrash to 1 more group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thrash practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Thrash's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Thrash is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Thrash's licenses on file in 2 states: Texas and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Thrash treats.

CMS data shows 2,214 Medicare services from Dr. Thrash across 15 procedure codes in 2024, for 455 Medicare patients. Medicare paid $95,287 for them. Every service was in an office.

CMS counts 455 Medicare patients who saw Dr. Thrash in 2024. The largest group is 65 to 74, with 220 patients. 74% of them have high cholesterol, and 56% have high blood pressure. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Thrash's median patient age at 57, with 58% women.

In 2024, Dr. Thrash wrote 655 Medicare Part D claims for 270 patients. 89% of them were for generic drugs. CMS names the drug for 506 of them, across 17 drugs with 11 or more claims each, at $228,543 in total drug cost. In 2023, CMS named 364 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Thrash for performance year 2024, reported as part of a group. Dr. Thrash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 654 procedures of removal of skin lesions by Dr. Thrash, more than 89% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 227 general payments to Dr. Thrash from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $904.

Dmand AI lists 2 awards for Dr. Thrash, most recently CMS Stage 1 EHR in 2012.

Dr. Thrash graduated from Joe R. & Teresa Lozano Long School of Medicine in 1999. Dr. Thrash is a member of AAD.

Dr. Thrash is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.